Isoproterenol	isoproterenol	CHEMICALS	O	OTHERS	I
induces	induces	O	O	O	O
primary	primary	O	O	O	O
loss	loss	O	O	O	O
of	of	O	O	O	O
dystrophin	dystrophin	O	O	O	O
in	in	O	O	O	O
rat	rat	O	O	O	O
hearts	hearts	O	O	O	O
:	:	O	O	O	O
correlation	correlation	O	O	O	O
with	with	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
mechanism	mechanism	O	O	O	O
of	of	O	O	O	O
isoproterenol-induced	isoproterenol-induced	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
damage	damage	O	DISEASE	OTHERS	I
is	is	O	O	O	O
unknown	unknown	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
a	a	O	O	O	O
mismatch	mismatch	O	O	O	O
of	of	O	O	O	O
oxygen	oxygen	CHEMICALS	O	OTHERS	I
supply	supply	O	O	O	O
vs.	vs.	O	O	O	O
demand	demand	O	O	O	O
following	following	O	O	O	O
coronary	coronary	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
and	and	O	O	O	O
myocardial	myocardial	O	O	OTHERS	I
hyperactivity	hyperactivity	O	DISEASE	OTHERS	I
is	is	O	O	O	O
the	the	O	O	O	O
best	best	O	O	O	O
explanation	explanation	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
complex	complex	O	O	O	O
morphological	morphological	O	O	O	O
alterations	alterations	O	O	O	O
observed	observed	O	O	O	O
.	.	O	O	O	O

Severe	severe	O	O	O	O
alterations	alterations	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
structural	structural	O	O	O	O
integrity	integrity	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
sarcolemma	sarcolemma	O	O	O	O
of	of	O	O	O	O
cardiomyocytes	cardiomyocytes	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
demonstrated	demonstrated	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
caused	caused	O	O	O	O
by	by	O	O	O	O
isoproterenol	isoproterenol	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Taking	taking	O	O	O	O
into	into	O	O	O	O
account	account	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
sarcolemmal	sarcolemmal	O	O	O	O
integrity	integrity	O	O	O	O
is	is	O	O	O	O
stabilized	stabilized	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
dystrophin-glycoprotein	dystrophin-glycoprotein	O	O	O	O
complex	complex	O	O	O	O
(	(	O	O	O	O
DGC	dgc	O	O	O	O
)	)	O	O	O	O
that	that	O	O	O	O
connects	connects	O	O	O	O
actin	actin	O	O	O	O
and	and	O	O	O	O
laminin	laminin	O	O	O	O
in	in	O	O	O	O
contractile	contractile	O	O	O	O
machinery	machinery	O	O	O	O
and	and	O	O	O	O
extracellular	extracellular	O	O	O	O
matrix	matrix	O	O	O	O
and	and	O	O	O	O
by	by	O	O	O	O
integrins	integrins	O	O	O	O
,	,	O	O	O	O
this	this	O	O	O	O
study	study	O	O	O	O
tests	tests	O	O	O	O
the	the	O	O	O	O
hypothesis	hypothesis	O	O	O	O
that	that	O	O	O	O
isoproterenol	isoproterenol	CHEMICALS	O	OTHERS	I
affects	affects	O	O	O	O
sarcolemmal	sarcolemmal	O	O	O	O
stability	stability	O	O	O	O
through	through	O	O	O	O
changes	changes	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
DGC	dgc	O	O	O	O
and	and	O	O	O	O
integrins	integrins	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
found	found	O	O	O	O
different	different	O	O	O	O
sensitivity	sensitivity	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
DGC	dgc	O	O	O	O
and	and	O	O	O	O
integrin	integrin	O	O	O	O
to	to	O	O	O	O
isoproterenol	isoproterenol	CHEMICALS	O	OTHERS	I
subcutaneous	subcutaneous	O	O	O	O
administration	administration	O	O	O	O
.	.	O	O	O	O

Immunofluorescent	immunofluorescent	O	O	O	O
staining	staining	O	O	O	O
revealed	revealed	O	O	O	O
that	that	O	O	O	O
dystrophin	dystrophin	O	O	O	O
is	is	O	O	O	O
the	the	O	O	O	O
most	most	O	O	O	O
sensitive	sensitive	O	O	O	O
among	among	O	O	O	O
the	the	O	O	O	O
structures	structures	O	O	O	O
connecting	connecting	O	O	O	O
the	the	O	O	O	O
actin	actin	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
cardiomyocyte	cardiomyocyte	O	O	O	O
cytoskeleton	cytoskeleton	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
extracellular	extracellular	O	O	O	O
matrix	matrix	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
sarcomeric	sarcomeric	O	O	O	O
actin	actin	O	O	O	O
dissolution	dissolution	O	O	O	O
occurred	occurred	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
reduction	reduction	O	O	O	O
or	or	O	O	O	O
loss	loss	O	O	O	O
of	of	O	O	O	O
dystrophin	dystrophin	O	O	O	O
.	.	O	O	O	O

Subsequently	subsequently	O	O	O	O
,	,	O	O	O	O
after	after	O	O	O	O
lysis	lysis	O	O	O	O
of	of	O	O	O	O
myofilaments	myofilaments	O	O	O	O
,	,	O	O	O	O
gamma-sarcoglycan	gamma-sarcoglycan	O	O	O	O
,	,	O	O	O	O
beta-dystroglycan	beta-dystroglycan	O	O	O	O
,	,	O	O	O	O
beta1-integrin	beta1-integrin	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
laminin	laminin	O	O	O	O
alpha-2	alpha-2	O	O	O	O
expressions	expressions	O	O	O	O
were	were	O	O	O	O
reduced	reduced	O	O	O	O
followed	followed	O	O	O	O
by	by	O	O	O	O
their	their	O	O	O	O
breakdown	breakdown	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
epiphenomena	epiphenomena	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
myocytolytic	myocytolytic	O	O	O	O
process	process	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
conclusion	conclusion	O	O	O	O
,	,	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
isoproterenol	isoproterenol	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
rats	rats	O	O	O	O
results	results	O	O	O	O
in	in	O	O	O	O
primary	primary	O	O	O	O
loss	loss	O	O	O	O
of	of	O	O	O	O
dystrophin	dystrophin	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
most	most	O	O	O	O
sensitive	sensitive	O	O	O	O
among	among	O	O	O	O
the	the	O	O	O	O
structural	structural	O	O	O	O
proteins	proteins	O	O	O	O
that	that	O	O	O	O
form	form	O	O	O	O
the	the	O	O	O	O
DGC	dgc	O	O	O	O
that	that	O	O	O	O
connects	connects	O	O	O	O
the	the	O	O	O	O
extracellular	extracellular	O	O	O	O
matrix	matrix	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
cytoskeleton	cytoskeleton	O	O	O	O
in	in	O	O	O	O
cardiomyocyte	cardiomyocyte	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
changes	changes	O	O	O	O
,	,	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
ischaemic	ischaemic	O	O	OTHERS	I
injury	injury	O	O	OTHERS	I
,	,	O	O	O	O
explain	explain	O	O	O	O
the	the	O	O	O	O
severe	severe	O	O	O	O
alterations	alterations	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
structural	structural	O	O	O	O
integrity	integrity	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
sarcolemma	sarcolemma	O	O	O	O
of	of	O	O	O	O
cardiomyocytes	cardiomyocytes	O	O	O	O
and	and	O	O	O	O
hence	hence	O	O	O	O
severe	severe	O	O	O	O
and	and	O	O	O	O
irreversible	irreversible	O	O	O	O
injury	injury	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
isoproterenol	isoproterenol	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

